Retinopathy of Prematurity Occurrence and Evaluation of Screening Policy in a Large Tertiary Greek Cohort

Overview

Journal Int Ophthalmol

Specialty Ophthalmology

Date 2019 Oct 24

PMID 31641909

Citations 3

Authors

Asimina Mataftsi

Stella Moutzouri

Paraskevi Karagianni

Nikolaos Ziakas

Vasiliki Soubasi

Periklis Brazitikos

Anna-Bettina Haidich

Affiliations

Soon will be listed here.

Abstract

Purpose: To assess the frequency of retinopathy of prematurity (ROP) and evaluate the appropriateness of screening guidelines in a tertiary hospital in Thessaloniki, Greece.

Methods: Retrospective review of consecutive infants admitted to the IInd Department of the Neonatal Care Unit of Aristotle University in the period April 2004-2015. ROP screening took place according to the Royal College of Paediatrics and Child Health and Royal College of Ophthalmologists (UK) guidelines [i.e. gestational age < 32 weeks and/or birth weight < 1501 g)], plus a few additional cases due to comorbidity.

Results: 1178 out of the 8782 admitted infants underwent ROP screening. ROP was detected in 232 (19.7%) infants of whom 87 developed severe form of the disease (i.e. ≥ stage 3). Treatment was required in 30 (2.5%) infants, all of whom fulfilled the screening criteria. Two of the 206 infants who were additionally screened due to comorbidity developed severe ROP which regressed spontaneously. Disease regression was achieved in 27/29 (93%) treated infants who survived.

Conclusions: The frequency of ROP observed in this cohort was as low as that reported in other developed countries. The currently used screening criteria permitted identification of all infants who were at risk and, therefore, need not be changed.

Citing Articles

Most Up-to-Date Analysis of Epidemiological Data on the Screening Guidelines and Incidence of Retinopathy of Prematurity in Europe-A Literature Review.

Modrzejewska M, Bosy-Gasior W J Clin Med. 2023; 12(11).

PMID: 37297844 PMC: 10253523. DOI: 10.3390/jcm12113650.

Efficacy and safety of Mydriatic Microdrops for Retinopathy Of Prematurity Screening (MyMiROPS): study protocol for a non-inferiority crossover randomized controlled trial.

Seliniotaki A, Haidich A, Lithoxopoulou M, Gika H, Boutou E, Virgiliou C Trials. 2022; 23(1):322.

PMID: 35428316 PMC: 9013111. DOI: 10.1186/s13063-022-06243-7.

Multicentre survey of retinopathy of prematurity in Indonesia.

Siswanto J, Bos A, Dijk P, Rohsiswatmo R, Irawan G, Sulistijono E BMJ Paediatr Open. 2021; 5(1):e000761.

PMID: 33532628 PMC: 7831712. DOI: 10.1136/bmjpo-2020-000761.

References

Fierson W . Screening examination of premature infants for retinopathy of prematurity. Pediatrics. 2013; 131(1):189-95. DOI: 10.1542/peds.2012-2996. View

Asproudis I, Andronikou S, Hotoura E, Kalogeropoulos C, Kitsos G, Psilas K . Retinopathy of prematurity and other ocular problems in premature infants weighing less than 1500 g at birth. Eur J Ophthalmol. 2003; 12(6):506-11. DOI: 10.1177/112067210201200610. View

Gilbert C, Fielder A, Gordillo L, Quinn G, Semiglia R, Visintin P . Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: implications for screening programs. Pediatrics. 2005; 115(5):e518-25. DOI: 10.1542/peds.2004-1180. View

. Multicenter trial of cryotherapy for retinopathy of prematurity. Preliminary results. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Arch Ophthalmol. 1988; 106(4):471-9. DOI: 10.1001/archopht.1988.01060130517027. View

. The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol. 2005; 123(7):991-9. DOI: 10.1001/archopht.123.7.991. View

Holmstrom G, Tornqvist K, Al-Hawasi A, Nilsson A, Wallin A, Hellstrom A . Increased frequency of retinopathy of prematurity over the last decade and significant regional differences. Acta Ophthalmol. 2017; 96(2):142-148. DOI: 10.1111/aos.13549. View

. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol. 2003; 121(12):1684-94. DOI: 10.1001/archopht.121.12.1684. View

Tabarez-Carvajal A, Montes-Cantillo M, Unkrich K, Trivedi R, Peterseim M . Retinopathy of prematurity: screening and treatment in Costa Rica. Br J Ophthalmol. 2017; 101(12):1709-1713. DOI: 10.1136/bjophthalmol-2016-310005. View

Ludwig C, Chen T, Hernandez-Boussard T, Moshfeghi A, Moshfeghi D . The Epidemiology of Retinopathy of Prematurity in the United States. Ophthalmic Surg Lasers Imaging Retina. 2017; 48(7):553-562. DOI: 10.3928/23258160-20170630-06. View

10.

Ziakas N, Cottrell D, Milligan D, Pennefather P, Bamashmus M, Clarke M . Regionalisation of retinopathy of prematurity (ROP) screening improves compliance with guidelines: an audit of ROP screening in the Northern Region of England. Br J Ophthalmol. 2001; 85(7):807-10. PMC: 1724044. DOI: 10.1136/bjo.85.7.807. View

11.

Chow L, Wright K, Sola A . Can changes in clinical practice decrease the incidence of severe retinopathy of prematurity in very low birth weight infants?. Pediatrics. 2003; 111(2):339-45. DOI: 10.1542/peds.111.2.339. View

12.

. An international classification of retinopathy of prematurity. The Committee for the Classification of Retinopathy of Prematurity. Arch Ophthalmol. 1984; 102(8):1130-4. DOI: 10.1001/archopht.1984.01040030908011. View

13.

Giapros V, Drougia A, Asproudis I, Theocharis P, Andronikou S . Low gestational age and chronic lung disease are synergistic risk factors for retinopathy of prematurity. Early Hum Dev. 2011; 87(10):653-7. DOI: 10.1016/j.earlhumdev.2011.05.003. View

14.

Painter S, Wilkinson A, Desai P, Goldacre M, Patel C . Incidence and treatment of retinopathy of prematurity in England between 1990 and 2011: database study. Br J Ophthalmol. 2014; 99(6):807-11. DOI: 10.1136/bjophthalmol-2014-305561. View

15.

Holmstrom G, Hellstrom A, Jakobsson P, Lundgren P, Tornqvist K, Wallin A . Evaluation of new guidelines for ROP screening in Sweden using SWEDROP - a national quality register. Acta Ophthalmol. 2014; 93(3):265-8. DOI: 10.1111/aos.12506. View

16.

. Retinopathy of prematurity: guidelines for screening and treatment. The report of a Joint Working Party of The Royal College of Ophthalmologists and the British Association of Perinatal Medicine. Early Hum Dev. 1996; 46(3):239-58. View

17.

Adams G, Bunce C, Xing W, Butler L, Long V, Reddy A . Treatment trends for retinopathy of prematurity in the UK: active surveillance study of infants at risk. BMJ Open. 2017; 7(3):e013366. PMC: 5372114. DOI: 10.1136/bmjopen-2016-013366. View

18.

Jefferies A . Retinopathy of prematurity: An update on screening and management. Paediatr Child Health. 2016; 21(2):101-8. PMC: 4807789. DOI: 10.1093/pch/21.2.101. View

19.

Quinn G, Barr C, Bremer D, Fellows R, Gong A, Hoffman R . Changes in Course of Retinopathy of Prematurity from 1986 to 2013: Comparison of Three Studies in the United States. Ophthalmology. 2016; 123(7):1595-600. PMC: 4921295. DOI: 10.1016/j.ophtha.2016.03.026. View

20.

Larsen P, Brunder M, Petrak M, Jehle V, Lagreze W, Holz F . [Screening for retinopathy of prematurity: Trends over the past 5 years in two German university hospitals]. Ophthalmologe. 2018; 115(6):469-475. DOI: 10.1007/s00347-018-0675-3. View